ESMO Breast 2024 | Next steps and clinical application of AI in oncology research

Flavia Jacobs • 16 May 2024

ESMO Breast 2024

Breast Cancer

Flavia Jacobs, MD, Humanitas Research Hospital, Milan, Italy, Humanitas Research Hospital, Milan, Italy, discusses the future directions of integrating machine learning and artificial intelligence (AI) tools into clinical practice. Emphasizing the potential of artificial intelligence to accelerate research and enhance clinical decision support, the discussion highlights how these technologies can analyze large datasets to provide faster, more accurate clinical insights. The implementation of AI in oncology promises significant advancements in patient care. This interview took place at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.